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Abstract 
 
Background 
The rapid growth of the older population is having a substantial impact on health and social 
care services in many societies across the world. Maintaining health and functioning in older 
age is a key public health issue but few studies have examined factors associated with 
inequalities in trajectories of health and functioning across countries. The aim of this study is 
to investigate trajectories of healthy ageing in older men and women and the impact of 
education and wealth on the trajectories. 
 
Methods 
This analysis was based on eight longitudinal cohorts from Australia, USA, Japan, South 
Korea, Mexico and Europe (N=141,214) harmonised by the EU Ageing Trajectories of 
Health: Longitudinal Opportunities and Synergies (ATHLOS) consortium. Multilevel 
modelling was used to investigate the impact of education and wealth on trajectories of 
healthy ageing scores, which incorporated 41 items of physical and cognitive functioning with 
a range between 0 (poor) and 100 (good). 
 
Findings 
Education and wealth affected baseline scores of healthy ageing but had minimal impacts on 
decline rates. Compared to those with primary or less education, participants with tertiary 
education had higher baseline scores (10∙54; 95% confidence interval (CI): 10∙31, 10∙77) 
adjusting for age, sex and cohort studies. The adjusted difference between lowest and highest 
quintiles of wealth was 8∙98 points (95% CI: 8∙74, 9∙22). Among the eight cohorts, the 
strongest inequality gradient was found in the Health Retirement Study from the USA. 
 
Interpretation 
The apparent difference in baseline scores suggests that cumulative disadvantage due to low 
education and wealth might have largely deteriorated health conditions in early life stages, 
leading to persistent differences throughout older age. Future research should adopt a 
lifecourse approach to investigate mechanisms of health inequalities across education and 
wealth in different societies. 
 
Funding 
European Union Horizon 2020 research and innovation programme (grant No 635316) 
 
 
 
Introduction 
Due to a decline in health status, increase of non-communicable diseases, disability and care 
dependence in later life, the rapid growth of the older population will lead to an increased 
burden on the already stretched health and social care services.1 To address the potential 
impact of population ageing, the concept of ‘healthy ageing’, which is defined by World 
Health Organization (WHO) as ‘the process of developing and maintaining the functional 
ability that enables wellbeing in older age’,2 has become a key topic in policy planning and 
health research. Functional ability focuses on having the capabilities that enable all people to 
meet their basic needs; to learn, grow and make decisions; to be mobile; to build and maintain 
relationships; and to contribute to society. This is made up of the interaction between intrinsic 
capacity, which combines all the individual’s physical and mental, psychosocial capacities, 
and environmental characteristics, which form the context of an individual’s life. This latest 
concept highlights the need to focus on positive aspects of ageing and the importance of 
considering both individual and contextual factors that may support health and functioning in 
later life. Whereas, traditional concepts in medical research, such as frailty, accumulated 
deficits or multimorbidity, have generally focused on negative aspects of health and on the 
identification of underlying biological and pathological abnormalities in older people.3,4 
 
Previous research on health inequalities has focused on a wide range of outcomes such as 
specific chronic diseases, multimorbidity, frailty and disability, mortality and life 
expectancy,5-7 where consistent socioeconomic inequalities according to factors such as 
education, occupational class and income have been reported. To provide a nuanced 
understanding of healthy ageing, it is important to investigate how the process of maintaining 
health and functioning differs across socioeconomic groups. A recent systematic review has 
summarised risk and protective factors related to healthy ageing.8 Several studies were 
identified that reported a positive impact of education and income on ageing outcomes, 
suggesting the existence of health inequalities in later life across different socioeconomic 
positions.8 However, existing studies have used diverse measures and analytical methods, 
leading to problems in study comparability. This has also hindered the assessment of factors 
that could be responsible for variations across countries.  
 
To provide a better understanding of healthy ageing, the Ageing Trajectories of Health: 
Longitudinal Opportunities and Synergies (ATHLOS) Project harmonised a wide range of 
sociodemographic, lifestyle, health and functioning factors from 17 ageing cohorts across the 
globe.9 The research team also developed a measure which incorporated multiple domains of 
physical and cognitive functioning and provided an indicator for healthy ageing across time 
and cohorts.10 Built on the ATHLOS work of data harmonisation and methodology 
development, the aim of this study is to investigate the impact of education and wealth on 
trajectories of healthy ageing and to examine whether health inequalities across education and 
wealth vary in diverse older populations.  
 
Methods 
Study population 
The ATHLOS Project9 brought together 17 ageing studies across the world and harmonised a 
wide range of lifestyle, social environment, physical and psychological health factors across 
different studies. Documentation of the harmonisation process can be accessed at: 
https://github.com/athlosproject/athlos-project.github.io. To estimate longitudinal changes in 
health status, the present analysis excluded cohorts with one- or two-wave investigations due 
to study design (N=192,114) and focused on the eight cohorts with at least three waves of data 
(N=141,214). This included the Australian Longitudinal Study of Ageing (ALSA),11 the 
English Longitudinal Study of Ageing (ELSA),12 the Study on Nutrition and Cardiovascular 
Health in Older Adults in Spain (Seniors-ENRICA),13 the Health and Retirement Study 
(HRS),14 the Japanese Study of Ageing and Retirement (JSTAR),15 the Korean Longitudinal 
Study of Ageing (KLOSA),16 the Mexican Health and Ageing Study (MHAS)17 and the 
Survey of Health Ageing and Retirement in Europe (SHARE).18  
 
Healthy ageing score 
Based on the WHO healthy ageing framework, researchers from the ATHLOS consortium 
reviewed measures of functional ability in the ageing cohorts and identified 41 items related 
to health, physical and cognitive functioning. These 41 items were harmonised into binary 
variables and item-response theory modelling was employed to generate a common measure 
for healthy ageing across cohorts.10 Using the baseline data of all individuals, a two parameter 
logistic model was fitted to incorporate all the items and estimate a latent trait score reflecting 
individual health and functioning level. The estimated parameters from baseline data were 
applied to follow-up waves and used to generate the scores at different time points. The scores 
were rescaled into a range between 0 and 100 and a higher score indicated better healthy 
ageing. More detailed information is provided in Supporting Information S2.  
 
Sociodemographic factors 
This analysis focused on five key factors: age, sex, cohort study, education and wealth. To 
align different baseline age across cohort studies, age was centred to 70 years old (age–70) as 
one of the cohort studies, ALSA, did not have participants aged 70 years or below. The 
ATHLOS harmonised dataset provided four levels of education qualification: less than 
primary education, primary, secondary and tertiary. Since some cohort studies had very few or 
no participants with less than primary education, the first two levels were combined and the 
three levels of education were: low (up to primary education), middle (secondary) and high 
(tertiary). Wealth was a harmonised variable indicating relative position of individuals within 
specific cohorts. Appropriate measures for personal or household income and finance (such as 
property, pension or insurance) were identified and divided into quintiles within cohorts (Q1: 
most deprived; Q5: most affluent). Comparable information was not available in Seniors-
ENRICA and therefore this specific analysis only included seven cohort studies. More 
detailed information on harmonisation is provided in Supporting Information S3.  
 
Analytical strategy 
Since multilevel modelling (MLM) can be more flexible when incorporating time variation in 
follow-up waves across different cohort studies,19 random-effect model using the MLM 
framework was conducted to investigate trajectories of health metric scores and examine the 
effect of sociodemographic factors accounting for non-independence of repeated measures 
over time. The model was fitted to estimate fixed and random effects of intercept (baseline 
scores) and slope (change per year) by years of follow-up, allowing an unstructured 
covariance matrix of intercept and slope. To examine the impact of sociodemographic factors 
on the trajectories, the analysis first focused on baseline age and sex and included linear and 
quadratic terms of age, and the interaction between age and sex in different models. Based on 
the descriptive information in Supporting Information S1, the gaps of healthy ageing scores 
became greater in older age groups (Figure S2) and varied across men and women (Figure 
S3). Thus, a quadratic term of age and interaction between age and sex were fitted to fully 
account for their impacts on the trajectories. A variable indicating cohort studies was added to 
the model including age and sex to investigate potential variations across the eight cohort 
studies adjusting for the two basic demographic factors. Two socioeconomic factors, 
education and wealth, were further added to the adjusted model including age, sex and study 
and we examined their effects on intercept and slope estimates. To investigate whether 
education and wealth might have different impacts on healthy ageing across different cohorts 
and sex, the analysis further included their interaction terms regressing on intercept and slope. 
To examine whether specific chronic conditions might explain health inequalities, five types 
of harmonised chronic diseases, including cardiovascular diseases, hypertension, diabetes, 
chronic respiratory diseases and joint disorders, were identified at baseline and added to the 
best model including demographic and socioeconomic factors. To investigate whether the 
effect of education varied across birth cohorts, interaction terms between birth cohort and 
education were included in modelling. Model fitness was assessed using Bayesian 
information criterion (BIC)20 with lower values indicating better model fit. To contextualise 
the inequality findings, country-level Gini coefficients for population aged 65 or above 
(https://data.oecd.org/) were obtained to compare with the score differences across education 
and relative wealth levels. 
 
Several sensitivity analyses were conducted. Quadratic terms of years of follow up were 
further added in the mixed models to investigate potential non-linear trajectories. Maximum 
likelihood estimation should provide unbiased estimates given the assumption of missing at 
random (MAR) mechanism.21 Since the percentages of missing data on education (N=2789, 
2∙0%) and wealth (N=4519, 3∙3%) were small in relation to the whole study population, 
results reported here are based on those with complete information on education or wealth. 
Loss of statistical power was unlikely to be an issue given the large number of study 
population. The distributions of education and wealth levels were also found to similar across 
follow-up waves (Table S3, Supporting Information). To account for potential missing not at 
random (MNAR) due to mortality, a joint model of longitudinal data on healthy ageing scores 
and survival data on all-cause mortality was fitted combining multilevel modelling and 
parametric Weibull survival regression.22 All analyses were based on the ATHLOS 
harmonised dataset version 1.7 and conducted using Stata 15.1. 
 
Role of the funding source 
The funders had no roles in study design, collection, analysis, interpretation of data, the 
writing of the report and the decision to submit the study for publication. The corresponding 
author had full access to all of the data and the final responsibility to submit for publication. 
 
Results 
Among the eight cohorts, the earliest studies started from 1992 (Table 1). Two larger cohorts, 
SHARE and HRS, recruited over 30,000 participants while ALSA and Seniors-ENRICA had 
less than 3,000. The length and frequency of follow-ups varied across studies. Most studies 
had follow-up every two years for a period of 10 years. The median follow-up period was six 
years with an interquartile range of nine years. ALSA had 13 waves over two decades while 
JSTAR only had 3 waves over four years.  
 
Among the 141,214 participants, the percentage of women was 54% (N=76,484) with a range 
from 47% (N=908) in ALSA and 57% (N=5,791) in KLOSA. The mean age at baseline was 
62∙9 years (SD=10∙1) and the range was between 45 and 106 years. MHAS had 78% of 
participants with primary or no formal education (N=10,627) while HRS (N=9,359), SHARE 
(N=15,170) and JSTAR (N=1,515) had less than 30% participants with low education. The 
mean healthy ageing score was 67∙5 (SD=17∙8) across all data and decreased from 69∙5 
(SD=17∙0) at baseline, 64∙1 (SD=18∙4) at year 10, to 62∙6 (SD=18∙2) at year 20. The 
distributions of healthy ageing scores by cohorts are provided in Table 1. 
 
Table 2 reports the associations between trajectories of healthy ageing scores, age and sex. 
For participants aged 70 years, the baseline score was estimated to be 68∙25 (95% CI: 68∙13, 
68∙37) and the decline rate was -1∙11 (95% CI: -1∙13, -1∙09) per year (Figure 1A). Older age 
was associated with a lower intercept in linear (-0∙66; 95% CI: -0∙68, -0∙65) and quadratic 
terms of age (-0∙02; 95% CI: -0∙02, -0∙01). Men had higher scores than women (4∙36; 95% CI: 
4∙18, 4∙54) and this difference increased with baseline age (0∙05; 95% CI: 0∙04, 0∙07) (Figure 
1B). The decline rate was slightly greater in men than women (-0∙02; 95% CI: -0∙04, 0∙00) but 
the effect size was small. After adjusting for age and sex, variation in intercept and slope was 
found across cohort studies (Figure 1C; Table S2, Supporting Information). Compared to 
HRS, a higher baseline score was found in JSTAR (8∙38; 95% CI: 7∙92, 8∙83) and a lower 
baseline in MHAS (-2∙85; 95% CI: -3∙15, -2∙56). Decline rates were generally greater in HRS 
and MHAS than other cohort studies. 
 
The associations between trajectories of health status, education and relative wealth are 
reported in Table 3. Both education and relative wealth had a strong influence on the baseline 
scores but a limited impact on decline rates after adjusting for age, sex and cohort study. 
Participants with secondary (5∙66; 95% CI: 5∙49, 5∙83) and tertiary education (10∙54; 95% CI: 
10∙31, 10∙77) had higher baseline scores than those with primary education or less. Higher 
level of wealth was associated with higher baseline scores and the difference between the 
least and most affluent quintiles was 8∙98 points (95% CI: 8∙74, 9∙22). The effect of education 
and relative wealth on baseline scores varied across cohort studies. ELSA, HRS, MHAS and 
SHARE had larger variation across education levels (Figure 2A). In these cohort studies, 
participants with secondary education had higher baseline scores by approximate 6 points and 
the difference increased to nearly 10 points for those with tertiary education. In JSTAR, 
Seniors-ENRICA, ALSA and KLOSA, the difference between high and low education was 
less than 6 points. Although most studies showed increasing baseline scores from the least to 
the most affluent quintiles, ELSA, HRS and SHARE had stronger gradients compared to other 
cohort studies (Figure 2B). Due to small numbers of ALSA participants in the third and fourth 
quintiles, the confidence intervals were very wide. When including both education and 
relative wealth in one model, the effect sizes remained similar across all cohort studies (Table 
S4, Supporting Information S4). Education and relative wealth had similar impacts on 
trajectories of healthy ageing scores in both men and women with very clear gradients from 
lowest to highest levels of education and relative wealth (Table S5, Supporting Information 
S4). Further adding chronic conditions did not reduce the gaps across education and wealth 
levels (Table S6-7, Supporting Information S4) and the effect of education did not vary across 
birth cohorts (Table S9, Supporting Information S4). The scatter plot of Gini coefficients and 
effect sizes of inequalities across education and wealth (Figure S6, Supporting Information 
S4) did not show clear patterns.  
 
The results of sensitivity analyses are provided in Supporting Information S5. Although the 
quadratic model showed better goodness of fit, the effect sizes of quadratic terms were small 
(Table S10, Supporting Information S5). The results of joint modelling showed a slightly 
greater decline rate (-1∙24; 95% CI: -1∙25, -1∙22) when including mortality data in the 
longitudinal analysis (Table S11, Supporting Information S5). A higher baseline score (Hazard 
ratio (HR): 0∙96; 95% CI: 0∙95, 0∙96) and slower decline rate (HR: 0∙57; 95% CI: 0∙55, 0∙58) 
were associated with lower risk of mortality after adjusting for age and sex. 
 
Discussion 
Using a harmonised dataset of eight ageing cohorts from USA, UK, Spain, Europe, Australia, 
Japan, Korea and Mexico, this study investigated changes in health and functioning over the 
ageing process and the potential impact of demographic and socioeconomic factors on the 
trajectories. Baselines scores and decline rates of healthy ageing scores varied across different 
age groups, sex and cohort studies. Education and wealth had a strong impact on baseline 
scores but almost no influence on the decline rates. Participants with lower levels of education 
and wealth generally had lower baseline healthy ageing scores but the effect sizes were 
different across cohort studies. Among the eight cohorts, the inequality gradients were found 
to be strongest in the HRS. 
 
The ATHLOS consortium harmonised data from different ageing cohorts across the globe and 
provides a large sample size for longitudinal analysis. This study focused on eight population-
based cohorts and included participants from different settings. Compared to harmonised 
datasets in the Gateway to Global Aging Data platform,23 this study incorporated additional 
cohort studies from Australia and Spain and an indicator for healthy ageing was generated 
comprising multiple domains of health and functioning measures across cohorts and follow-
up waves. The healthy ageing concept highlights ‘what a person can do in older age’ rather 
than ‘what kinds of symptoms and pathological abnormalities in an older patient’, which has 
been the focus of other relevant but distinct concepts such as frailty.4 While cognitive/motor 
reserve also focuses on functioning processes and neural network, reserve is mainly 
determined by factors in earlier life stages.24 On the other hand, healthy ageing is considered 
to be a process of maintaining functional ability and interactions between individual and 
environmental factors that can modify this process in later life.  
 
This study had some limitations. Most studies from low- and middle-income countries only 
had one or two waves of data and could not be included in this longitudinal analysis. Despite 
the process of data harmonisation, variation in methods of data collection or management 
across cohort studies might not be completely omitted and has to be considered when 
interpreting the findings. Variation in follow-up waves was accounted in multilevel modelling 
but only two studies (HRS and ALSA) had 20 years of follow-up and informed trajectories 
after 10 years of follow-up. The linear models might not sufficiently capture changes in 
decline rates particularly in the latter 10-year follow up period. However, decline rates 
seemed to be similar in the first 10-year period across cohorts and sensitivity analyses showed 
similar results. Another modelling approach could be using country as multilevel factor. Yet 
only SHARE included multiple countries and it would be difficult to generate specific 
estimates for each cohort study. Measures from different studies might collect slightly 
different information. Using the example of wealth quintiles, some studies only included a 
single question of household income while some used a series of questions to collect detailed 
income and financial information. Given such variation, we were not able to obtain a 
harmonised variable for absolute wealth and only focused on relative levels. The same issue 
might also affect items of the healthy ageing score. Variation in measurements might affect 
the associations between education, wealth and trajectories of healthy ageing. However, we 
adjusted for the study in the analysis and these two socioeconomic factors still had important 
impacts on baseline health scores. Although multiple imputation could be used to address 
missing or unavailable data on education and relative wealth,25 it was too challenging and 
computationally intensive to impute such large dataset while taking into account multilevel 
data structure. However, the effect sizes were unlikely to be over-estimated and statistical 
power should not be affected given the large study population. Some societal and historical 
factors such as health systems, welfare policies or economic crisis in different societies may 
affect health throughout the lifetime and explain health inequalities in later life. However, 
these measures were not available in the harmonised dataset. We attempted to include 
country-level Gini coefficients yet no apparaent relationships with health inequalities across 
education and relative wealth were observed. 
 
Education and wealth were found to have limited impacts on decline rates of healthy ageing 
scores in older people across different cohorts. This corresponds to an earlier SHARE 
analysis, which identified several indicators for early-life socioeconomic circumstances (such 
as number of books at home, housing quality and overcrowding) and reported their consistent 
associations with baseline levels of physical, cognitive and emotional functioning but not 
decline rates.26 Given lack of effect on decline rates, cumulative disadvantage due to low 
socioeconomic status might have largely deteriorated health conditions in early life stages and 
lead to persistent differences throughout older age.  
 
Inequalities in healthy ageing across education and wealth were apparent but the scale of the 
gradient varied across cohort studies. A wider gap was found in HRS, ELSA, MHAS and 
SHARE while the effect sizes were nearly half of the magnitude in other cohorts. This might 
be related to contextual factors in different societies, such as different absolute levels of 
income and material resources, variation in how education affects income or job 
opportunities, and also systematic differences in the distribution of education groups across 
sex, birth cohorts and time. Based on the theory of health inequality,27 education is widely 
used as a proxy measure for social position or status while wealth indicates a relative position 
in the income ladder. The subtle variation between these two measures might imply different 
pathways via material factors or behavioural and psychosocial factors. Wealth is likely to be 
related to material factors, such as financial difficulties, poor housing tenure, limited access to 
health care and insurance, which may have direct impacts on poor health across the lifetime 
and affect functional ability in older age.28,29 Education is likely to be related to behavioural 
and psychological factors such as smoking, diet and social support.27 These factors may also 
influence physical and mental health and capability to maintain functional ability in later life.8 
In this study, both education and relative wealth had independent effects on trajectories of 
healthy ageing scores across cohort studies and the effect sizes remained similar when further 
including chronic conditions. Pathways via material, behavioural and psychological factors 
might all be important and the role of environmental factors in supporting healthy ageing 
should be explored. 
 
The findings of this study highlight health inequalities in later life across education and 
wealth and their impacts may vary across different contexts. To identify potential mechanisms 
that explain the differential impact of education and wealth, a lifecourse approach is needed to 
understand how risk of poor health can accumulate since early life stages and investigate key 
material, behavioural and psychological factors that generate health inequalities in different 
societieis.27,30 More longitudinal studies need to be carried out in low- and middle-income 
countries in order to compare trajectories of healthy ageing across older populations living in 
various cultural, social and environmental contexts. This will inform policy planning on 
addressing determinants of healthy ageing across the world and reducing health inequalities in 
later life. 
 
 
 
 
 
 
 
 
 
 
 
 
Research in context 
Evidence before this study 
To summarise evidence on determinants of healthy ageing, the ATHLOS consortium has 
carried out a systematic review and a comprehensive report has been released on the project 
website in 2018. The search terms included ‘healthy ageing’ and other relevant terms such as 
‘successful/ positive/ productive/ optimising/ unimpaired/ robust/ effective ageing’. The 
literature search was conducted in MEDLINE, EMBASE, Psychinfo and Cochrane Central 
from inception up to August 2016. The review included all longitudinal cohort studies using 
‘healthy ageing’ as a main outcome measure. Since healthy ageing is considered a construct 
incorporating multiple domains of health, studies were excluded if a single component of 
healthy ageing (such as cognitive function, quality of life, or well-being alone) was used. 
There were no restrictions for language, time frame, setting, or characteristics of participants. 
Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. The initial 
search identified 89905 publications after duplicates removal and 65 longitudinal cohort 
studies met the inclusion criteria. Among the 65 included studies, 25 investigated the 
associations between education and healthy ageing and 14 focused on the associations with 
income and economic status. The risk of bias were low in these studies. Despite the 
heterogeneity of measurement methods, high levels of education and income were found to be 
beneficial to healthy ageing.   
 Added value of this study 
Although previous studies have suggested positive associations between education, income 
and healthy ageing, the strength of association reported from different cohorts may not be 
comparable due to variation in measurement methods. This study was based on a harmonised 
dataset of eight longitudinal cohorts from Australia, USA, Japan, South Korea, Mexico and 
Europe. Low levels of education and wealth was associated with poor health at baseline but 
had limited impacts on decline rates. The gradient of health inequalities at baseline differed 
across populations and the strongest gradient was found in the Health Retirement Study from 
the USA. 
 
Implications of all the available evidence 
Education and wealth appear to be important determinants of healthy ageing. To support 
maintenance of functional ability and reduce health inequalities in older age, public health 
policies should incorporate a lifecourse approach and address key determinants and risk 
factors from early life stages. Future research needs to understand how risk of poor health can 
accumulate over the lifecourse and investigate how variation in life experience, social, 
environmental and cultural factors can impact healthy ageing across different societies. 
 
Declaration of interests 
None. 
 
Acknowledgements 
This work was supported by the five-year Ageing Trajectories of Health: Longitudinal 
Opportunities and Synergies (ATHLOS) project. The ATHLOS project has received funding 
from the European Union’s Horizon 2020 research and innovation programme under grant 
agreement No 635316. The authors thank the ATHLOS Consortium for useful discussions and 
gratefully acknowledge the funding of institutions and the work of people who carried out the 
studies and provided data for this paper. 
 
Role of the funding source 
The funders had no roles in study design, collection, analysis, interpretation of data, the 
writing of the report and the decision to submit the study for publication. The corresponding 
author had full access to all of the data and the final responsibility to submit for publication. 
 
Data availability statement 
Documentation and metadata of the ATHLOS harmonisation process can be accessed at: 
https://github.com/athlosproject/athlos-project.github.io; https://athlos.pssjd.org. The original 
cohort data are publicly available (HRS, ELSA, KLOSA, MHAS, SHARE) or can be 
accessed via contacting the study management teams on reasonable request. 
 
Contributors 
YTW, CD and AMP developed the original idea and designed the approach. ASN organised 
data harmonisation and management. YTW conducted the data analysis. GMT supervised the 
analyses. All authors contributed to report writing and approved the final manuscript. 
 
Ethics committee approval 
This is a secondary data analysis project. All cohort studies have been approved by the 
relevant local research ethics committees. 
 
 
 
 
 
 
 
 
References 
1. Rechel B, Doyle Y, Grundy E, McKee M. How can health systems respond to population 
ageing? Geneva: World Health Organisation, 2009. Accessed 03/03/2020: 
http://www.euro.who.int/__data/assets/pdf_file/0004/64966/E92560.pdf  
2. World Health Organisation. World report on ageing and health 2015. Geneva: World 
Health Organisation, 2015. Accessed 03/03/2020: 
http://www.who.int/ageing/events/world-report-2015-launch/en/  
3. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of 
aging. TheScientificWorld. 2001;1:323–336. Doi:10.1100/tsw.2001.58. 
4. Belloni G, Cesari M. Frailty and intrinsic capacity: two related but distinct constructs. 
Frontiers in Medicine. 2019;6:133. Doi: 10.3389/fmed.2019.00133. 
5. Mackenbach JP, Kulhánová I, Artnik B, et al. Changes in mortality inequalities over two 
decades: register based study of European countries. BMJ. 2016;353. 
6. Hendi AS. Trends in U.S. life expectancy gradients: the role of changing educational 
composition. International Journal of Epidemiology 2015;44(3):946–955. doi: 
10.1093/ije/dyv062. 
7. Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Rayana TB, Schnitzler A. Social 
inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year 
follow-up of the Whitehall II cohort study. Lancet Public Health. 2020;5(1):e42-e50. Doi: 
10.1016/S2468-2667(19)30226-9. 
8. Kralj C, Daskalopoulou C, Rodríguez-Artalejo F, et al. Healthy ageing: a systematic 
review of risk factors. London: King’s College London, 2018. Accessed 03032020: 
http://athlosproject.eu/wp-content/uploads/2018/05/KIOPPN_HealthyAgeing-
Report2018.pdf 
9. Sanchez-Niubo A, Egea-Cortés L, Olaya B, et al. Cohort profile: the Ageing Trajectories 
of Health - Longitudinal Opportunities and Synergies (ATHLOS) project. Int J Epidemiol. 
2019;48(4):1052–1053i. Doi:10.1093/ije/dyz077. 
10. Caballero FF, Soulis G, Engchuan W, et al. Advanced analytical methodologies for 
measuring healthy ageing and its determinants, using factor analysis and machine learning 
techniques: the ATHLOS project. Sci Rep. 2017;7:43955. Doi:10.1038/srep43955. 
11. Luszcz MA, Giles LC, Anstey KJ, Browne-Yung KC, Walker RA, Windsor TD. Cohort 
profile: the Australian Longitudinal Study of Ageing (ALSA). Int J Epidemiol. 
2016;45(4):1054–1063. doi:10.1093/ije/dyu196. 
12. Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of 
ageing. Int J Epidemiol. 2013;42(6):1640–1648. doi:10.1093/ije/dys168. 
13. Ortolá R, Struijk EA, García-Esquinas E, Rodríguez-Artalejo F, Lopez-Garcia E. Changes 
in dietary intake of animal and vegetable protein and unhealthy aging. Am J Med. 2019 Jul 
29. doi: 10.1016/j.amjmed.2019.06.051. 
14. Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort Profile: the 
Health and Retirement Study (HRS). Int J Epidemiol. 2014;43(2):576–585. 
doi:10.1093/ije/dyu067. 
15. Hidehiko I, Satoshi S, Hideki H. JSTAR first results 2009 report. Research Institute of 
Economy, Trade and Industry (RIETI). 2009. Accessed 03032020: 
https://www.rieti.go.jp/jp/publications/dp/09e047.pdf. 
16. Park JH, Lim S, Lim JY, et al. An overview of the Korean Longitudinal Study on Health 
and Aging. Psychiatry Investig 2007;4:84–95.  
17. Wong R, Michaels-Obregon A, Palloni A. Cohort profile: the Mexican Health and Aging 
Study (MHAS). Int J Epidemiol 2017;46:e2. 
18. Börsch-Supan A, Brandt M, Hunkler C, et al. Data resource profile: the Survey of Health, 
Ageing and Retirement in Europe (SHARE). Int J Epidemiol. 2013;42(4):992–1001. 
doi:10.1093/ije/dyt088. 
19. Stoel RD, van den Wittenboer G, Hox J. Analyzing longitudinal data using multilevel 
regression and latent growth curve analysis. Metodologia de las Ciencias del 
Comportamiento. 2003;5(1):21-42. 
20. Schwarz GE. Estimating the dimension of a model. Annals of Statistics 1978;6(2):461–
464, doi:10.1214/aos/1176344136. 
21. Dong Y, Peng CY. Principled missing data methods for researchers. Springerplus. 
2013;2(1):222. doi:10.1186/2193-1801-2-222.  
22. Jones M, Mishra GD, Dobson A. Analytical results in longitudinal studies depended on 
target of inference and assumed mechanism of attrition. Journal of Clinical Epidemiology 
2015;68(10):1165–1175. 
23. Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015–2028. 
doi:10.1016/j.neuropsychologia.2009.03.004. 
24. Resche‐Rigon M, White IR, Bartlett JW, Peters SAE, Thompson SG, on behalf of the 
PROG‐IMT Study Group. Multiple imputation for handling systematically missing 
confounders in meta‐analysis of individual participant data. Statist. Med. 2013, 32 4890–
4905. Doi: 10.1002/sim.5894. 
25. Gateway to Global Ageing Data. https://g2aging.org/ (Accessed 03032020). 
26. Cheval B, Orsholits D, Sieber S, et al. Early-life socioeconomic circumstances explain 
health differences in old age, but not their evolution over time. J Epidemiol Community 
Health 2019;73:703–711. 
27. Bartley M. Health Inequality: an introduction to theories, concepts and methods, 2nd 
Edition. Cambridge: Polity Press, 2016. 
28. Skalická V, van Lenthe F, Bambra C, Krokstad S, Mackenbach J. Material, psychosocial, 
behavioural and biomedical factors in the explanation of relative socio-economic 
inequalities in mortality: evidence from the HUNT study. Int J Epidemiol. 
2009;38(5):1272-84. doi: 10.1093/ije/dyp262.  
29. van Oort FV, van Lenthe FJ, Mackenbach JP. Material, psychosocial, and behavioural 
factors in the explanation of educational inequalities in mortality in The Netherlands. J 
Epidemiol Community Health. 2005;59(3):214-20. 
30. Kuruvilla S, Sadana R, Montesinos EV, et al. A life-course approach to health: synergy 
with sustainable development goals. Bulletin of the World Health Organization 
2018;96(1):42–50. doi:10.2471/BLT.17.198358. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure legends 
 
Figure 1. Estimated healthy ageing scores by baseline age, sex and cohort study 
Figure 2. Differences in baseline healthy ageing scores across education levels and wealth 
quintiles by cohort studies (adjusted for age and sex) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables 
 
Table 1. Characteristics of study population by eight cohort studies 
Cohort Location Baseline age (years) Sex Baseline/last 
follow up year 
Number 
of wave 
Low education 
(<primary): N (%) 
Missing=2789 (2·0%) 
Wealth (least affluent 
quintile): N (%) 
Missing=4519 (3·3%) 
Number of 
participants 
Health status 
scores: Mean 
(SD) 
Mean (SD) [range] Women: N (%) 
ALSA Australia 77∙5 0(5∙9) [70, 103] 908 (46∙6) 1992/2014 13 602 (36∙7) 701 (37∙3) 1947 56∙8 (14∙0) 
ELSA UK 62∙8 0(9∙6) [50, 94] 7977 (53∙1) 2002/2015 7 5516 (39∙4) 2600 (18∙6) 15010 66∙4 (16∙8) 
ENRICA Spain 68∙7 0(6∙4) [60, 93] 1338 (53∙1) 2008/2015 3 1373 (54∙5) N/A 2519 67∙3 (14∙8) 
HRS US 61∙20 (9∙8) [50, 103] 18044 (53∙7) 1992/2012 11 9359 (27∙9) 6974 (20∙8) 33580 65∙6 (18∙9) 
JSTAR Japan 62∙9 0(7∙1) [50, 77] 2616 (50∙8) 2007/2011 3 1515 (29∙6) 677 (25∙2) 5144 76∙9 (13∙5) 
KLOSA S. Korea 61∙5 (11∙0) [45, 105] 5791 (56∙5) 2006/2012 4 4651 (45∙4) 2097 (20∙9) 10254 68∙9 (15∙6) 
MHAS Mexico 62∙5 0(9∙6) [50, 106] 7310 (53∙8) 2001/2012 3 10627 (78∙3) 3128 (24∙0) 13601 63∙9 (16∙5) 
SHARE Europe 64∙20 (9∙9) [50, 103] 32500 (54∙9) 2004/2013 5 15170 (26∙3) 11463 (19∙5) 59159 71∙1 (17∙1) 
Total  62∙9 (10∙1) [45, 106] 76484 (54∙2)   48813 (35∙3) 27640 (20∙6) 141214 67∙5 (17∙8) 
 
ALSA: Australian Longitudinal Study of Ageing; ELSA: English Longitudinal Study of Ageing; Seniors-ENRICA: Study on Nutrition and Cardiovascular 
Health in Older Adults in Spain; HRS: Health and Retirement Study (HRS); JSTAR: Japanese Study of Ageing and Retirement; KLOSA; Korean Longitudinal 
Study of Ageing; MHAS: Mexican Health and Ageing Study; SHARE: Survey of Health Ageing and Retirement in Europe 
 
Table 2. The association between trajectories of health metrics, age and sex 
 Model 1 Model 2 Model 3 
 Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 68∙25 (68∙13, 68∙37) 66∙21 (66∙07, 66∙36) 66∙19 (66∙05, 66∙34) 
 Age (years, at baseline) -0∙65 (-0∙66, -0∙64) -0∙66 (-0∙68, -0∙65) -0∙66 (-0∙67, -0∙65) 
 Age2 -0∙02 (-0.02, -0.02) -0∙02 (-0∙02, -0∙01) -0∙02 (-0∙02, -0∙01) 
 Sex (men vs women)  4∙36 (4∙18, 4∙54) 4∙41 (4∙22, 4∙59) 
 Age*sex  0∙05 (0∙04, 0∙07) 0∙05 (0∙04, 0∙07) 
Decline rate (by year of follow-up) -1∙11 (-1.13, -1.09) -1.11 (-1∙12, -1∙09) -1∙10 (-1∙12, -1∙08) 
 Age (years, at baseline) -0∙06 (-0∙06, -0∙06) -0∙06 (-0∙06, -0∙06) -0∙06 (-0∙06, -0∙06) 
 Age2 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 
 Sex (men vs women)   -0∙02 (-0∙04, 0∙00) 
    
Variance    
 Intercept 180∙53 (178∙81, 182∙27) 176∙33 (174∙63, 178∙04) 176∙32 (174∙63, 178∙03) 
 Slope 0∙79 (0∙77, 0∙81) 0∙79 (0∙77, 0∙81) 0∙79 (0∙77, 0∙81) 
 Covariance -2∙08 (-2∙24, -1∙92) -2∙08 (-2∙24, -1∙91) -2∙07 (-2∙23, -1∙91) 
 Residual 83∙46 (83∙02, 83∙90) 83∙48 (83∙04, 83∙93) 83∙48 (83∙04, 83∙92) 
Goodness of fit    
 BIC 3854387 3851659 3851668 
 
 
 
 
 
 
 
 
 
Table 3. The association between education, wealth and trajectories of health metrics 
(adjusted for age, sex and cohort study) 
 Education  Wealth  
 Model 1 Model 2 Model 1 Model 2 
 Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 60∙18 (59∙96, 60∙41) 58∙97 (58∙85, 59∙48) 60∙53 (60∙28, 60∙77) 55∙74 (55∙38, 56∙10) 
Education     
 Middle vs Low 5∙66 (5∙49, 5∙83) 6∙80 (6∙44, 7∙15)   
 High vs Low 10∙54 (10∙31, 10∙77) 13∙48 (13∙02, 13∙94)   
Relative wealth     
Q2 vs Q1   2∙24 (2∙00, 2∙47) 6∙17 (5∙70, 6∙65) 
Q3 vs Q1   4∙13 (3∙89, 4∙36) 9∙91 (9∙44, 10∙39) 
Q4 vs Q1   6∙55 (6∙32, 6∙79) 13∙14 (12∙66, 13∙62) 
Q5 vs Q1   8∙98 (8∙74, 9∙22) 16∙34 (15∙86, 16∙82) 
Decline rate 
(by year of follow-up) 
 
-1∙26 (-1∙28, -1∙24) 
 
-1∙28 (-1∙31, -1∙25) 
 
-1∙27 (-1∙29, -1∙24) 
 
-1∙19 (-1∙23, -1∙16) 
Education     
 Middle vs Low  0∙01 (-0∙03, 0∙04)   
 High vs Low  0∙04 (0∙00, 0∙09)   
Relative wealth     
Q2 vs Q1    -0∙08 (-0∙13, -0∙03) 
Q3 vs Q1    -0∙13 (-0∙18, -0∙08) 
Q4 vs Q1    -0∙11 (-0∙16, -0∙06) 
Q5 vs Q1    -0∙08 (-0∙13, -0∙03) 
Goodness of fit     
 BIC 3778816 3778487 3703900 3702573 
 
 
 
 
 
Figure 1. Estimated healthy ageing scores by baseline age, sex and cohort study 
(A) Baseline age 
 
 
(B) Baseline age and sex 
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(C) Cohort study (adjusted for age and sex) 
 
ALSA: Australian Longitudinal Study of Ageing; ELSA: English Longitudinal Study of Ageing; Seniors-ENRICA: 
Study on Nutrition and Cardiovascular Health in Older Adults in Spain; HRS: Health and Retirement Study (HRS); 
JSTAR: Japanese Study of Ageing and Retirement; KLOSA; Korean Longitudinal Study of Ageing; MHAS: 
Mexican Health and Ageing Study; SHARE: Survey of Health Ageing and Retirement in Europe 
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Figure 2. Differences in baseline healthy ageing scores across education levels and wealth 
quintiles by cohort studies (adjusted for age and sex) 
(A) Education (Low: primary education or less; Middle: secondary education; High: tertiary education) 
 
(B) Wealth (Cohort-specific quintiles; Q1: least affluent; Q5: most affluent) 
 
ALSA: Australian Longitudinal Study of Ageing; ELSA: English Longitudinal Study of Ageing; Seniors-ENRICA: 
Study on Nutrition and Cardiovascular Health in Older Adults in Spain; HRS: Health and Retirement Study (HRS); 
JSTAR: Japanese Study of Ageing and Retirement; KLOSA; Korean Longitudinal Study of Ageing; MHAS: 
Mexican Health and Ageing Study; SHARE: Survey of Health Ageing and Retirement in Europe 
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Krystyna Szafraniec, Andrzej Pająk, Matilde Leonardi, Davide Guido, Alberto Raggi, Anna Goodman, Ilona 
Koupil, Demosthenes Panagiotakos, Abdonas Tamosiunas, Ricardas Radisauskas, Sergei Scherbov, Warren 
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(ATHLOS) project. The ATHLOS project has received funding from the European Union’s Horizon 2020 research 
and innovation programme under grant agreement No 635316. The ATHLOS project researchers are grateful for 
data contribution and funding in the following studies: 
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S2. ATHLOS healthy ageing score 
(A) Data 
Based on the WHO framework,1 the ATHLOS research team reviewed information in the included cohort studies2 
and identified the items which might indicate underlying concept of healthy ageing, ‘the process of developing 
and maintaining functional ability that enables wellbeing in older age’. The selected items mainly focused on 
physical and cognitive functioning as they are key to maintain functional ability in daily life. A small number of 
items related to health such as pain, sleep problems, level of energy were also selected as they were considered to 
strongly influence functional performance. The selected items were harmonised across the 17 cohorts and 
dichotomised into binary variables (0 = Presence of difficulties, 1 = Absence of difficulties). The 41 items used to 
generate healthy ageing scores included: 
 
1. Difficulties with memory. 
2. Dizzines problems when walking on a level surface. 
3. Difficulties with orientation in time. 
4. Walking speed (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than the 
25th percentile of the distribution). 
5. Level of energy experienced at the time of the interview. 
6. Sleeping problems. 
7. Self-reported pain experienced at the time of the interview. 
8. Loss of urine beyond control. 
9. Difficulty for hearing. 
10. Difficult for hearing what is said in a conversation. 
11. Difficulties in eye sight using glasses or corrective lens as usual. 
12. Difficulties for seeing things at a distance, using glasses or corrective lens as usual. 
13. Difficulties for seeing things up close, using glasses or corrective lens as usual. 
14. Difficulty for walking by yourself and without using any special equipment. 
15. Difficulty for sitting for long periods. 
16. Difficulty for getting up from sitting down. 
17. Difficulty for climbing one or several flights of stairs. 
18. Difficulty with stooping, kneeling, or crouching. 
19. Difficulty for reaching or extending arms. 
20. Difficulty pulling or pushing large objects. 
21. Difficulty for lifting or carrying weights. 
22. Difficulty for picking up things with fingers. 
23. Difficulties for using the toilet (limitations in Activities of Daily Living). 
24. Difficulties for bathing or showering (limitations in Activities of Daily Living). 
25. Difficulty for getting dressed (limitations in Activities of Daily Living). 
26. Difficulties for eating (limitations in Activities of Daily Living). 
27. Difficulties for getting in or out of bed (limitations in Activities of Daily Living). 
28. Difficulties for moving around the home (limitations in Activities of Daily Living). 
29. Difficulties for doing housework (limitations in Instrumental Activities of Daily Living). 
30. Difficulties for preparing meals (limitations in Instrumental Activities for Daily Living). 
31. Difficulties for using telephone (limitations in Instrumental Activities of Daily Living) 
32. Difficulties for taking medications (limitations in Instrumental Activities of Daily Living). 
33. Difficulties for managing money (limitations in Instrumental Activities of Daily Living). 
34. Difficulties for using a map (limitations in Instrumental Activities of Daily Living). 
35. Difficulties for shopping for groceries (limitations in Instrumental Activities of Daily Living). 
36. Difficulties for getting out of home (limitations in Instrumental Activities of Daily Living). 
37. Immediate recall (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than 
the 25th percentile of the distribution). 
38. Verbal fluency (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than the 
25th percentile of the distribution). 
39. Processing speed (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than 
the 25th percentile of the distribution). 
40. Delayed recall (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than the 
25th percentile of the distribution). 
41. Numeracy (Low – Lower than the 25th percentile of the distribution; Moderate or high – Higher than the 
25th percentile of the distribution). 
 
Documentation of the ATHLOS harmonization can be accessed at: https://github.com/athlosproject/athlos-
project.github.io. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) Statistical analyses 
To generate a common measure for healthy ageing across cohort studies, the analysis focused on baseline data of 
all participants aged 18 years or above from 16 cohort studies (N=343915). Item response theory (IRT)3,4 modelling 
was used to incorporate 41 items related to health, physical and cognitive functioning and estimate latent trait 
scores for individuals based on the unidimensionality assumption (Figure S1).  
 
Figure S1. IRT modelling structure 
  
 
 
 
 
 
 
 
 
Compared to traditional approach of calculating a total score, IRT models can take into account variation in 
response patterns and generate corresponding latent trait scores to reflect such variation.5 A two parameter logistic 
IRT model was fitted to estimate the relationships between the underlying concept of healthy ageing (θ) for 
individual j (θj) and items (y1…y41) using the following formula: 
 
logit[Pr(yij=1|θj)]=ai(θj−bi) 
 
Given certain level of θ, the probability of absence of specific difficulty i was determined by two parameters: a, 
item discrimination, and b, item difficulty. The estimated latent trait score (θ) followed a normal distribution with 
a mean of 0 and a variance of 1. The model fitness was assessed using Root Mean Square Error of Approximation 
(RMSEA<0.06), Comparative Fit Index (CFI>0.95) and Tucker-Lewis index (TLI>0.95).6  
 
To test measurement invariance across different cohort studies, a logistic regression framework was used to 
estimate differential item functioning (DIF)7 and ensure the relationships between item and latent (a, b) were 
similar across cohorts. If DIF were detected, the Stocking-Lord Equating approach was carried out to rescale study-
specific parameters so the estimated scores were comparable across cohorts.8,9 To check validity of the healthy 
ageing scores, the analysis further investigated the associations between the scores, mortality and healthy life 
expectancy at the country level. The parameters estimated from the baseline data were applied to follow-up waves 
with the assumption of measurement invariance over time. Since the longitudinal analysis needs at least three 
waves of data, this study focused on the scores in the eight longitudinal cohorts. To improve interpretation of the 
results, the latent trait scores were transferred into a range between 0 and 100. 
 
 
Item 1 (y1) Item 41 (y41) 
Healthy ageing  
(θj) 
… Item 2 (y2) 
 (C) Descriptive information 
Descriptive information on the eight longitudinal cohorts is reported here. The mean score was 67∙5 (standard 
deviation=17∙8) and the median was 68∙2 (interquartile range=26∙5). Since most cohort studies had follow-up 
every two years, Figure S2 shows histograms of healthy ageing scores by every two years in the eight longitudinal 
cohorts. The distributions were slightly skewed to left. Most participants in the eight cohorts were generally healthy. 
 
Figure S3 reports mean scores by age group and year of follow-up. The healthy ageing scores decreased with years 
of follow-up. At baseline (Year 0), the score differences became greater in older age groups and the gap remained 
apparent across follow-up period. This indicated the effect of age was not linear and a quadratic term should be 
included in the modelling of trajectories. Figure S4 shows mean scores by age group and sex. Within the same age 
groups, men generally had higher scores than women and the differences increased with older age. Figure S5 
shows baseline mean scores by cohort studies and age group. Within the same age group, the mean score of the 
Japanese cohort (JSTAR) was higher than other cohort studies and lower scores were found in the Mexican cohort 
(MHAS).   
 
 
Figure S2. Histograms of healthy ageing scores by years of follow-up in the eight longitudinal cohorts  
(Year 0, 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20) 
 
 
 
 
Figure S3. Mean scores by baseline age group over time 
 
 
 
Figure S4. Mean scores by baseline age group and sex over time (m: men; f: women) 
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Figure S5. Baseline mean scores by cohort studies and age group (m: men; f: women) 
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S3. Harmonisation of education and relative wealth variables 
The ATHLOS research team has established a standardised process of harmonisation. Researchers in the 
collaboration reviewed relevant information from all included cohorts and identified appropriate measures for 
harmonisation of specific variables such as education and relative wealth. Table S1.1 and S1.2 report the original 
variables that were used in harmonisation of education and relative wealth in the eight longitudinal cohort studies. 
The Github links for R codes are also provided.  
 
Table S1.1: Harmonisation of education 
 Original variable name and label in the cohort Link to harmonisation codes 
ALSA TYPQUAL: Highest qualification https://github.com/athlosproject/athlos-
project.github.io/blob/master/ALSA/1_Soc
iodemo_econom/5_education.Rmd 
ELSA edqual: Educational qualification https://github.com/athlosproject/athlos-
project.github.io/blob/master/ELSA/1_Soc
iodemo_econom/5_education.Rmd 
ENRICA p61: Maximum level of studies that have you 
completed 
https://github.com/athlosproject/athlos-
project.github.io/blob/master/ENRICA/1_
Sociodemo_econom/5_education.Rmd 
HRS RAEDUC: Respondent education (category) https://github.com/athlosproject/athlos-
project.github.io/blob/master/HRS/1_Soci
odemo_econom/5_education.Rmd 
JSTAR a_002_a: Highest school https://github.com/athlosproject/athlos-
project.github.io/blob/master/JSTAR/1_So
ciodemo_econom/5_education.Rmd 
KLOSA w01A003: Education background https://github.com/athlosproject/athlos-
project.github.io/blob/master/KLOSA/1_S
ociodemo_econom/5_education.Rmd 
MHAS a3_1: Level of education https://github.com/athlosproject/athlos-
project.github.io/blob/master/MHAS/1_So
ciodemo_econom/5_education.Rmd 
SHARE isced_r: ISCED-97 coding of education https://github.com/athlosproject/athlos-
project.github.io/blob/master/SHARE/1_S
ociodemo_econom/5_education.Rmd 
 
 
 
 
 
Table S1.2: Harmonisation of relative wealth 
 Variable name in the original cohort: label Link to harmonisation codes 
ALSA TTLINCYR: Total gross income https://github.com/athlosproject/athlos-
project.github.io/blob/master/ALSA/1_Soc
iodemo_econom/13_Wealth.Rmd 
ELSA yq5_bu_s: Quintiles of benefit unit equivalised 
income 
https://github.com/athlosproject/athlos-
project.github.io/blob/master/ELSA/1_Soc
iodemo_econom/13_Wealth.Rmd 
ENRICA   
HRS H1ITOT: Total HHold (respondent and spouse) https://github.com/athlosproject/athlos-
project.github.io/blob/master/HRS/1_Soci
odemo_econom/13_Wealth.Rmd 
JSTAR e_013_1: Net income bracket https://github.com/athlosproject/athlos-
project.github.io/blob/master/JSTAR/1_So
ciodemo_econom/13_Wealth.Rmd 
KLOSA w01E126: Total income last year  https://github.com/athlosproject/athlos-
project.github.io/blob/master/KLOSA/1_S
ociodemo_econom/13_Wealth.Rmd 
MHAS K8_1, K9A1, K9B1, K9C1, K8_2, K9A2, K9B2, 
K9C2, K11_1, K12A1, K12B1, K12C1, K11_2, 
K12A2, K12B2, K12C2, K22_1, K23A1, K23B1, 
K23C1, K22_2, K23A2, K23B2, K23C2, K31_3, 
K32A3, K32B3, K32C3, K34_3, K35A3, K35B3, 
K35C3, K40, K41A, K41B, K41C, K42, K45a_3, 
K45b_3, K45c_3, K44A_1, K44B1, K44B2, 
K44B3, K45A_1, K45B1, K45B2, K45B3, 
K47A_1, K47B1, K47B2, K47B3, K48A_1, 
K48B1, K48B2, K48B3, K50A_1, K51B1, K51B2, 
K51B3, K53A_1, K53B1, K53B2, K53B3, 
K54A_1, K54B1, K54B2, K54B3, K58_1, K59A1, 
K59B1, K59C1, K58_2, K59A2, K59B2, K59C2, 
K58_3, K59A3, K59B3, K59C3, K58_4, K59A4, 
K59B4, K59C4, K64_1, K65A1, K65B1, K65C1, 
K64_2, K65A2, K65B2, K65C2, K64_3, K65A3, 
K65B3, K65C3, K64_4, K65A4, K65B4, K65C4, 
K77_1, K77_2, K80_1, K80_2, K83e, K80c, 
K25_1, K26A1, K26B1, K26C1, K25_2, K26A2, 
K26B2, K26C2, K31_1, K32A1, K32B1, K32C1, 
https://github.com/athlosproject/athlos-
project.github.io/blob/master/MHAS/1_So
ciodemo_econom/13_Wealth.Rmd 
K34_1, K35A1, K35B1, K35C1, K31_2, K32A2, 
K32B2, K32C2, K34_2, K35A2, K35B2, K35C2, 
K51A_1, K51B1, K51B2, K51B3 
SHARE income_pct_w1: household income percentiles https://github.com/athlosproject/athlos-
project.github.io/blob/master/SHARE/1_S
ociodemo_econom/13_Wealth.Rmd 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S4. Additional results 
(A) Cohort study 
 
Table S2: Results of models including cohort studies (adjusted for age and gender) 
 Model 1 Model 2 
 Coeff. (95% CI) Coeff. (95% CI) 
Baseline scores 63∙37 (63∙17, 63∙57) 63∙95 (63∙74, 64∙15) 
 HRS Reference Reference 
 ALSA 2∙02 (1∙38, 2∙67) 0∙95 (0∙27, 1∙62) 
 ELSA 0∙31 (0∙05, 0∙58) -0∙72 (-1∙00, -0∙44) 
 ENRICA 4∙67 (4∙11, 5∙24) 2∙89 (2∙26, 3∙52) 
 JSTAR 8∙98 (8∙55, 9∙40) 8∙38 (7∙92, 8∙83) 
 KLOSA 2∙17 (1∙87, 2∙48) 1∙27 (0∙94, 1∙60) 
 MHAS -2∙62 (-2∙90, -2∙34) -2∙85 (-3∙15, -2∙56) 
 SHARE 4∙88 (4∙69, 5∙07) 3∙99 (3∙79, 4∙19) 
Decline rates -1∙07 (-1∙09, -1∙05) -1∙26 (-1∙28, -1∙24) 
 HRS  Reference 
 ALSA  0∙41 (0∙32, 0∙49) 
 ELSA  0∙33 (0∙30, 0∙36) 
 ENRICA  0∙57 (0∙48, 0∙66) 
 JSTAR  0∙23 (0∙11, 0∙36) 
 KLOSA  0∙32 (0∙27, 0∙37) 
 MHAS  0∙06 (0∙03, 0∙09) 
 SHARE  0∙36 (0∙33, 0∙39) 
 
Variance 
  
 Intercept 169∙33 (167∙69, 170∙99) 168∙73 (167∙10, 170∙38) 
 Slope 0∙79 (0∙76, 0∙81) 0∙76 (0∙74, 0∙78) 
 Covariance -2∙30 (-2∙46, -2∙14) -2∙14 (-2∙29, -1∙98) 
 Residual 83∙49 (83∙05, 83∙94) 83∙46 (83∙02, 83∙90) 
   
Goodness of fit   
 BIC 3846028 3845106 
 
ALSA: Australian Longitudinal Study of Ageing; ELSA: English Longitudinal Study of Ageing; HRS: Health 
and Retirement Study (HRS); JSTAR: Japanese Study of Ageing and Retirement; KLOSA; Korean Longitudinal 
Study of Ageing; MHAS: Mexican Health and Ageing Study; SHARE: Survey of Health Ageing and Retirement 
in Europe 
 
 
 
 
 
(B) Education and relative wealth 
 
Table S3: Numbers and percentage of education and relative wealth levels in follow-up waves 
 Education   Wealth     
wave Low Middle High Q1 Q2 Q3 Q4 Q5 
1 48813 
(35∙3) 
66895 
(48∙3) 
22717 
(16∙4) 
27640 
(20∙6) 
26826 
(20∙0) 
26824 
(20∙0) 
26000 
(19∙4) 
26886 
(20∙0) 
2 48813 
(35∙3) 
66895 
(48∙3) 
22717 
(16∙4) 
27640 
(20∙6) 
26826 
(20∙0) 
26824 
(20∙0) 
26000 
(19∙4) 
26886 
(20∙0) 
3 37884 
(40∙1) 
42158 
(44∙7) 
14372 
(15∙2) 
18370 
(20∙3) 
17855 
(19∙8) 
18232 
(20∙2) 
17533 
(19∙4) 
18365 
(20∙3) 
4 19852 
(32∙1) 
31316 
(50∙7) 
10623 
(17∙2) 
12091 
(19∙5) 
12238 
(19∙7) 
12646 
(20∙4) 
12163 
(19∙6) 
12972 
(20∙9) 
5 11625 
(29∙4) 
20637 
(52∙3) 
7219 
(18∙3) 
7661 
(19∙2) 
7917 
(19∙8) 
7770 
(19∙5) 
8004 
(20∙1) 
8558 
(21∙4) 
6 7464 
(29∙5) 
13676 
(54∙0) 
4189 
(16∙5) 
4766 
(18∙5) 
5019 
(19∙5) 
4957 
(19∙3) 
5202 
(20∙2) 
5774 
(22∙5) 
7 6197 
(27∙8) 
12271 
(55∙1) 
3814 
(17∙1) 
4021 
(17∙8) 
4334 
(19∙2) 
4350 
(19∙3) 
4676 
(20∙7) 
5198 
(23∙0) 
8 4352 
(26∙0) 
9416 
(56∙3) 
2950 
(17∙7) 
3038 
(18∙1) 
3363 
(20∙1) 
3260 
(19∙5) 
3396 
(20∙3) 
3711 
(22∙1) 
9 3337 
(27∙5) 
6811 
(56∙0) 
2009 
(16∙5) 
2138 
(17∙5) 
2457 
(20∙2) 
2381 
(19∙5) 
2483 
(20∙4) 
2736 
(22∙4) 
10 2857 
(26∙3) 
6155 
(56∙7) 
1850 
(17∙0) 
1867 
(17∙1) 
2174 
(20∙0) 
2140 
(19∙6) 
2241 
(20∙6) 
2472 
(22∙7) 
11+ 2191 
(24∙6) 
5184 
(58∙2) 
1536 
(17∙2) 
1636 
(18∙2) 
1995 
(22∙2) 
1669 
(18∙6) 
1708 
(19∙0) 
1968 
(21∙9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S4: Results of model including both education and relative wealth (adjusted for age and sex) 
 ALSA ELSA HRS JSTAR KLOSA MHAS SHARE 
Education        
 Low Reference Reference Reference Reference Reference Reference Reference 
 Middle 1∙51 
(0∙15, 2∙86) 
4∙42 
(3∙91, 4∙94) 
4∙02 
(3∙67, 4∙37) 
3∙94 
(2∙73, 5∙15) 
3∙42 
(2∙84, 4∙00) 
4∙87 
(4∙22, 5∙53) 
5∙27 
(4∙99, 5∙54) 
 High 2∙17 
(-0∙78, 5∙12) 
7∙67 
(6∙93, 8∙40) 
8∙42 
(7∙95, 8∙89) 
4∙15 
(2∙41, 5∙90) 
4∙65 
(3∙72, 5∙57) 
7∙99 
(6∙96, 9∙03) 
9∙22 
(8∙87, 9∙57) 
Wealth        
 Q1 (least affluent) Reference Reference Reference Reference Reference Reference Reference 
 Q2 -0∙54 
(-1∙96, 0∙89) 
-0∙11 
(-0∙86, 0∙63) 
5∙23  
(4∙79, 5∙68) 
0∙99 
(-0∙62, 2∙59) 
0∙48 
(-0∙33, 1∙30) 
0∙31 
(-0∙41, 1∙02) 
1∙11 
(0∙75, 1∙46) 
 Q3 -2∙49 
(-9∙84, 4∙85) 
1∙45 
(0∙71, 2∙19) 
8∙12 
(7∙67, 8∙58) 
1∙69 
(0∙13, 3∙24) 
0∙93 
(0∙15, 1∙71) 
0∙83 
(0∙11, 1∙54) 
1∙96 
(1∙60, 2∙32) 
 Q4 7∙31 
(-0∙31, 14∙93) 
4∙20  
(3∙46, 4∙94) 
10∙71 
(10∙25, 11∙18) 
2∙42  
(0∙73, 4∙12) 
2∙19 
(1∙31, 3∙07) 
1∙81 
(1∙08, 2∙53) 
3∙43 
(3∙06, 3∙79) 
 Q5 (most affluent) 0∙19 
(-1∙64, 2∙02) 
6∙94 
(6∙19, 7∙70) 
12∙79 
(12∙31, 13∙28) 
2∙70 
(1∙07, 4∙33) 
3∙90 
(3∙03, 4∙78) 
2∙54 
(1∙78, 3∙29) 
4∙75 
(4∙38, 5∙12) 
 
ALSA: Australian Longitudinal Study of Ageing; ELSA: English Longitudinal Study of Ageing; HRS: Health 
and Retirement Study (HRS); JSTAR: Japanese Study of Ageing and Retirement; KLOSA; Korean Longitudinal 
Study of Ageing; MHAS: Mexican Health and Ageing Study; SHARE: Survey of Health Ageing and Retirement 
in Europe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S5: The effects of education and relative wealth on women and men (adjusted for age and study) 
 Education Wealth 
 Women Men Women Men 
Education     
 Low Reference Reference   
 Middle 6∙64 (6∙42, 6∙86) 5∙65 (5∙40, 5∙90)   
 High 11∙27 (10∙95, 11∙59) 10∙92 (10∙60, 11∙23)   
Wealth     
 Q1 (least affluent)   Reference Reference 
 Q2   2∙51 (2∙21, 2∙81) 2∙05 (1∙67, 2∙43) 
 Q3   4∙13 (3∙82, 4∙45) 4∙40 (4∙03, 4∙77) 
 Q4   6∙56 (6∙24, 6∙89) 6∙92 (6∙56, 7∙29) 
 Q5 (most affluent)   8∙91 (8∙58, 9∙23) 9∙51 (9∙14, 9∙87) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(C) Chronic diseases 
This analysis focused on five types of harmonised chronic diseases at baseline: cardiovascular diseases (14.6% 
participants with the condition), hypertension (36.1%), diabetes (11.9%), chronic respiratory diseases (7.3%) and 
joint disorders (26.5%). Cardiovascular diseases included any of the following conditions: angina, stroke, 
myocardial infarction, heart attack, coronary heart disease, congestive heart failure, heart murmur, valve disease 
or cerebral vascular disease. Chronic respiratory diseases included asthma, emphysema, chronic pulmonary 
disease, chronic obstructive pulmonary disease or chronic bronchitis. Joint disorders included arthritis, rheumatism 
or osteoarthritis. The five chronic diseases were added to the models including demographic (age, sex, cohort 
study) and socioeconomic factors (education or wealth) to investigate whether these chronic diseases could explain 
the associations between education, relative wealth and healthy ageing scores. The results are reported in Table S6 
(education) and Table S7 (relative wealth). Although all chronic diseases were found to be associated with lower 
healthy ageing scores at baseline, the effect sizes of education and relative wealth remained similar when adding 
different chronic diseases. This indicated that inequalities across education and relative wealth could not be 
explained by these chronic diseases. 
 
 
 
 
 
 
Table S6: The impact of chronic diseases on health inequalities across education 
 Education +Cardiovascular 
diseases 
+Hypertension +Diabetes +Chronic respiratory 
diseases 
+Joint disorders 
 Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 60∙18 (59∙96, 60∙41) 62∙61 (62∙38, 62∙83) 62∙75 (62∙52, 62∙99) 61∙58 (61∙34, 61∙82) 60∙89 (60∙66, 61∙11) 65∙18 (64∙96, 65∙41) 
Education       
 Middle vs Low 5∙66 (5∙49, 5∙83) 5∙55 (5∙38, 5∙72) 5∙59 (5∙42, 5∙77) 5∙62 (5∙43, 5∙81) 5∙52 (5∙35, 5∙70) 5∙03 (4∙86, 5∙20) 
 High vs Low 10∙54 (10∙31, 10∙77) 10∙17 (9∙95, 10∙40) 10∙31 (10∙08, 10∙54) 10∙45 (10∙19, 10∙71) 10∙35 (10∙12, 10∙57) 9∙62 (9∙41, 9∙84) 
Specific chronic condition       
 Yes vs No  -9∙69 (-9∙91, -9∙47) -4∙83 (-4∙99, -4∙67) -7∙42 (-7∙67, -7∙17) -8∙60 (-8∙89, -8∙31) -10∙73 (-10∙91, -10∙56) 
       
Decline rate 
(by year of follow-up) 
 
-1∙26 (-1∙28, -1∙24) 
 
-1∙29 (-1∙32, -1∙27) 
 
-1∙26 (-1∙29, -1∙24) 
 
-1∙25 (-1∙28, -1∙23) 
 
-1∙27 (-1∙29, -1∙25) 
 
-1∙38 (-1∙40, -1∙35) 
Specific chronic condition       
Yes vs No  0∙13 (0.10, 0.16) 0∙00 (-0∙02, 0∙03) -0∙15 (-0∙19, -0∙12) 0∙14 (0∙10, 0∙18) 0∙31 (0∙28, 0∙33) 
       
Goodness of fit       
 BIC 3778816 3673166 3736997 3245326 3738391 3727416 
 
All models were adjusted for age, sex and study. Cardiovascular diseases: angina, stroke, myocardial infarction, heart attack, coronary heart disease, congestive heart failure, 
heart murmur, valve disease, cerebral vascular disease; Chronic respiratory diseases: asthma, emphysema, chronic pulmonary disease, chronic obstructive pulmonary disease 
or chronic bronchitis; Joint disorders: arthritis, rheumatism or osteoarthritis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S7: The impact of chronic diseases on health inequalities across relative wealth quintiles 
 Relative wealth +Cardiovascular 
diseases 
+Hypertension +Diabetes +Chronic respiratory 
diseases 
+Joint disorders 
 Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 60∙53 (60∙28, 60∙77) 63∙01 (62∙76, 63∙26) 63∙18 (62∙93, 63∙44) 61∙59 (61∙32, 61∙86) 61∙23 (60∙99, 61∙48) 65∙18 (64∙96, 65∙41) 
Relative wealth       
Q2 vs Q1 2∙24 (2∙00, 2∙47) 2∙18 (1∙95, 2∙41) 2∙21 (1∙97, 2∙44) 2∙39 (2.13, 2∙66) 2∙19 (1∙96, 2∙43) 2∙13 (1∙90, 2∙35) 
Q3 vs Q1 4∙13 (3∙89, 4∙36) 3∙95 (3∙71, 4∙18) 4∙08 (3∙85, 4∙31) 4∙55 (4∙28, 4∙81) 4∙04 (3∙81, 4∙28) 3∙82 (3∙60, 4∙05) 
Q4 vs Q1 6∙55 (6∙32, 6∙79) 6∙21 (5∙97, 6∙44) 6∙42 (6∙19, 6∙66) 7.02 (6∙75, 7∙29) 6∙42 (6∙18, 6∙66) 5∙95 (5∙72, 6∙18) 
Q5 vs Q1 8∙98 (8∙74, 9∙22) 8∙52 (8∙28, 8∙75) 8∙74 (8∙50, 8∙98) 9∙41 (9∙14, 9∙68) 8∙76 (8∙53, 9∙00) 8∙22 (7∙99, 8∙44) 
Specific chronic condition       
 Yes vs No  -9∙69 (-9∙91, -9∙47) -4∙92 (-5.09, -4∙76) -7∙44 (-7∙69, -7∙18) -8∙70 (-8∙99, -8∙40) -10∙91 (-11∙09, -10∙74) 
       
Decline rate 
(by year of follow-up) 
 
-1∙27 (-1∙29, -1∙24) 
 
-1∙30 (-1∙32, -1∙28) 
 
-1∙27 (-1∙29, -1∙25) 
 
-1∙26 (-1∙28, -1∙24) 
 
-1∙28 (-1∙30, -1∙26) 
 
-1∙38 (-1∙41, -1∙36) 
Specific chronic condition       
Yes vs No  0∙13 (0.10, 0.16) 0∙00 (-0∙02, 0∙03) -0∙16 (-0∙20, -0∙12) 0∙15 (0∙11, 0∙20) 0∙31 (0∙29, 0∙34) 
       
Goodness of fit       
 BIC 3703900 3603596 3736997 3170443 3668617 3657537 
 
All models were adjusted for age, sex and study. Cardiovascular diseases: angina, stroke, myocardial infarction, heart attack, coronary heart disease, congestive heart failure, 
heart murmur, valve disease, cerebral vascular disease; Chronic respiratory diseases: asthma, emphysema, chronic pulmonary disease, chronic obstructive pulmonary disease 
or chronic bronchitis; Joint disorders: arthritis, rheumatism or osteoarthritis 
 
 
 
 
 
 
 
 
 
 
 
 
 
(D) Birth cohort 
Among all birth cohorts, a greater difference was found between 1940-1949 and 1930-1939 (Table S8). This cut-
off also corresponds to World War II and therefore the birth cohort were combined into two groups: post-war (after 
1940) and pre-war (before 1939). 
  
The effect of birth cohort on baseline and slope of healthy ageing scores was small when adjusting for age, gender 
and study (Table S9). Absolute level of education can change over generations while relative wealth should be 
stable across birth cohorts. Thus, this analysis only focused on education and their interactions with birth cohorts. 
The interaction terms between education and birth cohort indicate limited difference between post- and pre-war 
birth cohorts.  
 
Table S8: Mean and standard deviation of the healthy ageing scores by baseline age group and birth 
cohort 
   Birth cohort    
Age group 
(years) 
Post 1950 1940-1949 1930-1939 1920-1929 1910-1919 Pre 1909 
45-49 79∙9 (13∙5)      
50-54 76∙0 (15∙3) 70∙9 (16∙1) 67∙1 (16∙6)    
55-59 73∙7 (16∙0) 73∙1 (15∙2) 65∙7 (17∙0)    
60-64 73∙7 (16∙2) 73∙3 (14∙9) 66∙7 (16∙3) 66∙0 (16∙7)   
65-69  72∙2 (14∙9) 69∙1 (15∙5) 68∙4 (17∙0)   
70-74  69∙5 (16∙6) 67∙2 (15∙8) 66∙3 (17∙2) 67∙0 (16∙7)  
75-79   62∙6 (16∙3) 61∙2 (16∙4) 64∙1 (16∙6)  
80-84   60∙0 (15∙8) 57∙0 (16∙6) 58∙1 (16∙6) 57∙7 (15∙7) 
85-89    52∙4 (17∙2) 50∙2 (16∙8) 54∙7 (15∙6) 
90+    47∙3 (15∙6) 44∙7 (16∙3) 45∙0 (16∙6) 
 
 
 
 
 
 
 
 
 
 
 
 
Table S9. The effect of birth cohort and education on trajectories of healthy ageing 
 Model 1 Model 2 Model 3 
 Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 60∙06 (59∙74, 60∙38) 60∙38 (60∙04, 60∙70) 59∙92 (59∙58, 60∙26) 
Education    
 Middle vs Low 5∙66 (5∙49, 5∙83) 5∙66 (5∙49, 5∙84) 5∙73 (5∙49, 5∙97) 
 High vs Low 10∙54 (10∙31, 10∙77) 10∙55 (10∙32, 10∙77) 11∙05 (10∙75, 11∙34) 
Birth cohort    
Pre- vs post-war 0∙13 (-0∙10, 0∙36) -0∙16 (-0∙41, 0∙08) 0∙35 (0∙05, 0∙66) 
Interaction terms    
Pre-war*Middle   -0∙03 (-0∙36, 0∙30) 
Pre-war*High   -1∙36 (-1∙82, -0∙91) 
Decline rate 
(by year of follow-up) 
 
-1∙26 (-1∙28, -1∙24) 
 
-1∙28 (-1∙31, -1∙25) 
 
-1∙26 (-1∙28, -1∙24) 
Birth cohort    
Pre- vs post-war  0∙12 (0∙09, 0∙15)  
Goodness of fit    
 BIC 3778828 3778791 3778814 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(E) Gini coefficient and inequality 
To contextualise the inequality findings, Gini coefficients for population aged 65 or above in Australia, UK, Spain, 
USA, Japan, South Korea and Mexico were obtained from the OECD database (https://data.oecd.org/). Figure S6 
shows Gini coefficients by countries in relation to the effect sizes of education (high vs low) and relative wealth 
(Q5 vs Q1) across the eight cohort studies. No clear patterns were observed. 
 
Figure S6. Scatter plot of Gini coefficients (0: no inequality; 1: high inequality) and effect sizes of 
inequalities across education (blue; baseline difference between high and low) and wealth (orange; 
baseline difference between Q5 and Q1) 
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Gini coefficients 
S5. Sensitivity analyses 
 
(A) Quadratic model 
 
Table S10: Random effect models including quadratic terms of follow-up years 
 Model 1 Model 2 Model 3 
 Coeff (95% CI) Coeff (95% CI) Coeff (95% CI) 
Baseline score 67∙68 (67∙56, 67∙80) 65∙64 (65∙49, 65∙78) 65∙58 (65∙43, 65∙73) 
 Age (years, at baseline) -0∙64 (-0∙65, -0∙63) -0∙65 (-0∙66, -0∙64) -0∙65 (-0∙66, -0∙64) 
 Age2 -0∙01 (-0∙02, -0∙01) -0∙01 (-0∙01, -0∙01) -0∙01 (-0∙01, -0∙01) 
 Sex (men vs women)  4∙45 (4∙26, 4∙63) 4∙52 (4∙33, 4∙70) 
 Age*sex  0∙05 (0∙04, 0∙07) 0∙05 (0∙04, 0∙07) 
Decline rate (by year of 
follow-up) 
 
-0∙63 (-0∙65, -0∙61) 
 
-0∙63 (-0∙66, -0∙60) 
 
-0∙58 (-0∙62, -0∙55) 
 Age (years, at baseline) -0∙07 (-0∙07, -0∙07) -0∙07 (-0∙07, -0∙06) -0∙07 (-0∙07, -0∙07) 
 Age2 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 
 Sex (men vs women)   -0∙10 (-0∙14, -0∙06) 
Changes in decline rate over 
time 
 
-0∙04 (-0∙05, -0∙04) 
 
-0∙04 (-0∙05, -0∙04) 
 
-0∙05 (-0∙05, -0∙04) 
 Age (years, at baseline) 0∙00 (0∙00∙ 0∙00) 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 
 Age2 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 
 Sex (men vs women)   0∙01 (0∙00, 0∙01) 
Variance    
 Constant 179∙63 (177∙83, 181∙45) 175∙21 (173∙44, 176∙99) 175∙19 (173∙42, 176∙97) 
 Slope 2∙80 (2∙71, 2∙90) 2∙80 (2∙71, 2∙90) 2∙80 (2∙70, 2∙90) 
 Quadratic 0∙01 (0∙01, 0∙01) 0∙01 (0∙01, 0∙01) 0∙01 (0∙01, 0∙01) 
 Cov (cons, slope) -2∙24 (-2∙58, -1∙90) -2∙17 (-2∙51, -1∙83) -2∙15 (-2∙49, -1∙81) 
 Cov (cons, Q) -0∙08 (-0∙11, -0∙06) -0∙09 (-0∙11, -0∙07) -0∙09 (-0∙11, -0∙07) 
 Cov (slope, Q) -0∙12 (-0∙12, -0∙11) -0∙12 (-0∙12, -0∙11) -0∙12 (-0∙12, -0∙11) 
 Residual 77∙34 (76∙79, 77∙78) 77∙36 (76∙92, 77∙80) 77∙36 (76∙92, 77∙80) 
Goodness of fit    
 BIC 3847143 3844345 3844348 
 
 
 
 
 
 
Figure S7: Estimated healthy ageing scores by baseline age 
 
 
 
Figure S8: Estimated healthy ageing scores over time by age and sex 
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(B) Joint models including longitudinal and mortality data 
 
Table S11: Results of joint models including longitudinal data on healthy ageing scores and mortality 
 Model 1 Model 2 
Longitudinal Coeff. (95% CI) Coeff. (95% CI) 
Baseline score 68∙26 (68∙14, 68∙37) 66∙22 (66∙08, 66∙37) 
Age (years, at baseline) -0∙65 (-0∙65, -0∙64) -0∙65 (-0∙66, -0∙64) 
Age2 -0∙02 (-0∙02, -0∙01) -0∙01 (-0∙02, -0∙01) 
Sex (men vs women)  4∙33 (4∙14, 4∙51) 
Age*sex  0∙04 (0∙02, 0∙05) 
Decline rate (by year of follow-up) -1∙24 (-1∙25, -1∙22) -1∙21 (-1∙23, -1∙19) 
Age (years, at baseline) -0∙07 (-0∙07, -0∙07) -0∙07 (-0∙07, -0∙07) 
Age2 0∙00 (0∙00, 0∙00) 0∙00 (0∙00, 0∙00) 
Sex (men vs women)  -0∙05 (-0∙07, -0∙03) 
   
Survival HR (95% CI) HR (95% CI) 
Baseline score 0∙96 (0∙96, 0∙96) 0∙96 (0∙95, 0∙96) 
Year of follow-up 0∙58 (0∙56, 0∙59) 0∙57 (0∙55, 0∙58) 
Baseline age 1∙11 (1∙11, 1∙11) 1∙11 (1∙11, 1∙11) 
Sex (men vs women)  1∙48 (1∙44, 1∙52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
